Bright Health Group Reaffirms FY21 Sales Guidance $4.1B-$4.2B vs $4.13B Est., Sees FY22 Sales $6.3B-$6.5B vs $5.87B Est.

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.